Breaking News

ANNUAL REPORT 2023 | Unveiling TIF’s Impactful Achievements
WORLD PATIENT SAFETY DAY 2024 | Get It Right, Make It Safe!
REGULATORY APPROVAL | PiaSky Becomes the First Monthly Treatment for PNH in the EU
ACCESS TO INNOVATION | UK Greenlights Gene-Editing Therapy Casgevy for β-Thalassaemia Treatment
GLOBAL SURVEY | Understanding the Thalassaemia Community Health Literacy & Its Impact on Care
Understanding the Thalassaemia Community Health Literacy and Its Impact on Care
JUST LISTEN | Voices of PK Deficiency Episode on the Impact of New International Standards
NEW APPROVAL | FDA Endorses Piasky for Paroxysmal Nocturnal Hemoglobinuria
CAD | Enjaymo Not Cost-Effective at Current Price, According to US Study
SPOTLIGHT | TIF Wins Prestigious HemaSphere Award at EHA2024

English

Menu

Home
Who we are
What we do
Haemoglobin Disorders
Positions & Policies
Publications
Media Centre
- News
- Newsletters
- Events
- Videos
Contact us

Search for

Home/Media Centre

Media Centre

Also see

Twitter updates

Tweets by thalassaemiaTIF

Subscribe to our channel

Quick links

For Patients
For Healthcare Professionals
For Associations
For Supporters
TIF Members
Useful Links
Sitemap

Follow us

Facebook
X
LinkedIn
YouTube
Instagram
RSS

© Copyright 2024, All Rights Reserved |

Powered by Genestial

Transparency Statement | Privacy Policy

Back to top button

Close

Facebook
X
LinkedIn
YouTube
Instagram
RSS

Search for: